Sitemap
Medical science
11/2004 Effects of epidural-and-general anesthesia combined versus general anesthesia alone on the venous hemodynamics of the lower limb. A randomized study
11/2004 Warfarin prophylaxis and venous thromboembolism in the first 5 days following hip and knee arthroplasty
11/2004 Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients
11/2004 Thrombin activatable fibrinolysis inhibitor and its fibrinolytic effect in normal pregnancy
11/2004 Fibrinogen adsorption and platelet adhesion to metal and carbon coatings
11/2004 Glanzmann thrombasthenia Frankfurt I is associated with a point mutation Thr176Ile in the N-terminal region of IIb subunit integrin
11/2004 Oxidative status of platelets in normal and thalassemic blood
11/2004 Association between the Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in a multiethnic population in South London
11/2004 Neutrophils stimulated by apolipoprotein(a) generate fragments that are stronger inhibitors of plasmin formation than apo(a)
11/2004 Strenuous, acute exercise suppresses polymorphonuclear leukocyte respiratory burst under adherence to surface-adherent platelets in men
11/2004 The effect of homocysteine reduction by B-vitamin supplementation on markers of endothelial dysfunction
11/2004 Amino acid mutagenesis within ligand-binding loops in v confers loss-of-function or gain-of-function phenotype on integrin v3
11/2004 The K+-channel opener NS1619 increases endothelial NO-synthesis involving p42/p44 MAP-kinase
11/2004 High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stenting
11/2004 Percutaneous endoluminal arterial cryoenergy improves vascular remodelling after angioplasty
11/2004 Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study
11/2004 Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors
11/2004 An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF
11/2004 Therapeutic monitoring of immunosuppressant drugs. Where are we?
11/2004 Therapeutic drug monitoring of non-tricyclic antidepressant drugs
11/2004 The relevance of therapeutic drug monitoring in plasma and erythrocytes in anti-cancer drug treatment
11/2004 Therapeutic drug monitoring of old and newer anti-epileptic drugs
11/2004 Pharmacogenomic genotyping methodologies
11/2004 Hair analysis in toxicology
11/2004 Oral fluid as a diagnostic tool
11/2004 Position of immunological techniques in screening in clinical toxicology
11/2004 Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control
11/2004 Systematic toxicological analysis by high-performance liquid chromatography with diode array detection (HPLC-DAD)
11/2004 Analysis of ?-hydroxybutyric acid, DL-lactic acid, glycolic acid, ethylene glycol and other glycols in body fluids by a direct injection gas chromatography-mass spectrometry assay for wide use
11/2004 Difficult delivery of the impacted fetal head during cesarean section: intraoperative disengagement dystocia
11/2004 Breech presenting twin A: is vaginal delivery safe?
11/2004 Maternal serum interleukin-1?, -6 and -8 levels and potential determinants in pregnancy and peripartum
11/2004 Comparison between HELLP syndrome, chronic hypertension, and superimposed preeclampsia on chronic hypertension without HELLP syndrome
11/2004 Fetal scalp pH and ST analysis of the fetal ECG as an adjunct to CTG. A multi-center, observational study
11/2004 Effects of nitric oxide and prostacyclin on hemodynamic response by big endothelin-1 in near term fetal sheep
11/2004 Strategy for management of newborns with cervical teratoma
11/2004 Predicting neonatal outcomes: birthweight, body mass index or ponderal index?
11/2004 Markers of platelets activation, CD 62P and soluble P-selectin in healthy term neonates
11/2004 Detection of parvovirus B19, cytomegalovirus and enterovirus infections in cases of intrauterine fetal death
11/2004 Plasma endothelin-1 and clinical manifestations of neonatal sepsis
11/2004 Noncompaction of the left ventricular myocardium diagnosed in pregnant woman and neonate
11/2004 Ventricular bigeminy misdiagnosed as fetal bradycardia by cardiotocography – the value of non-invasive fetal electrocardiography
11/2004 Prolonged fetal bradycardia as the presenting clinical sign in Streptococcus agalactiae chorioamnionitis
11/2004 Changes of blood pressure and heart rate variability precede a grand mal seizure in a pregnant woman
11/2004 Myocardial infarction in early pregnancy
12/2004 A marriage of enhancement: fibrinolysis and conjunctive therapy
12/2004 Variable extent of clopidogrel responsiveness in patients after coronary stenting
12/2004 The indazole derivative YD-3 inhibits thrombin-induced vascular smooth muscle cell proliferation and attenuates intimal thickening after balloon injury
12/2004 Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of -fibrinogen genotype and environmental factors. The HIFMECH Study
12/2004 Aspirin and coronary artery disease
12/2004 Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular disease
12/2004 Comparison of two methods to assess variability of platelet response to anti-platelet therapies in patients with acute coronary syndrome undergoing angioplasty
12/2004 Admission troponin T, advanced age and male gender identify patients with improved myocardial tissue perfusion after abciximab administration for ST-segment elevation myocardial infarction
12/2004 Combined effects of a factor Xa inhibitor YM466 and a GPIIb/IIIa antagonist YM128 on thrombosis and neointima formation in mice
12/2004 Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure
12/2004 Hepatitis C in haemophiliacs
12/2004 Prostaglandin E2- activates channel-mediated calcium entry in human erythrocytes: an indication for a blood clot formation supporting process
12/2004 Genetic variation in Fc receptor IIa protects against advanced peripheral atherosclerosis. The Rotterdam Study
12/2004 Inhibition of plasma kallikrein by C1-inhibitor: role of endothelial cells and the amino-terminal domain of C1-inhibitor
12/2004 Gradually glycosylated protein C mutants (Arg178Gln and Cys331Arg) are degraded by proteasome after mannose trimming
12/2004 Hypofibrinogenaemia associated with a novel heterozygous 289 Ala Val substitution (fibrinogen Dorfen)
12/2004 In vitro comparison of the effect of fondaparinux and enoxaparin on whole blood tissue factor-triggered thromboelastography profile
12/2004 Anti-CD40 antibodies in antiphospholipid syndrome and systemic lupus erythematosus
12/2004 Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis
12/2004 von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women
12/2004 The effect of natural habituation on coagulation responses to acute mental stress and recovery in men
12/2004 Treatment of venous thromboembolism with vitamin K antagonists: patients health state valuations and treatment preferences
12/2004 Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project
12/2004 Human platelets contain forms of factor V in disulfide-linkage with multimerin
12/2004 Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells potential role of prostaglandin E2
Back
Search
